Literature DB >> 19681993

Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine.

Bart T Endrizzi1, Peter K Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19681993     DOI： 10.1111/j.1524-4725.2009.01277.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN： 1076-0512            Impact factor:   3.398


× No keyword cloud information.
  6 in total

Review 1.  Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients.

Authors:  Haider K Bangash; Oscar R Colegio
Journal:  Curr Treat Options Oncol       Date:  2012-09

2.  [Skin cancer in organ transplant patients. Epidemiology and management].

Authors:  U Leiter; C Garbe
Journal:  Hautarzt       Date:  2010-03       Impact factor: 0.751

3.  Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma.

Authors:  Jiyoung Rhee; Jaemin Jo; Sang-Hoon Han; Jung-Mi Kwon
Journal:  Ann Dermatol       Date:  2019-02-28       Impact factor: 1.444

Review 4.  Management of High-Risk Squamous Cell Carcinoma of the Skin.

Authors:  Teresa Fu; Sumaira Z Aasi; S Tyler Hollmig
Journal:  Curr Treat Options Oncol       Date:  2016-07

5.  Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios.

Authors:  Komal Akhtar; Metlapalli Venkata Sravanthi; Josephine D'Angelo; Abirami Sivapiragasam
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

Review 6.  Advances in the management of cutaneous squamous cell carcinoma.

Authors:  Sonal A Parikh; Vishal A Patel; Desiree Ratner
Journal:  F1000Prime Rep       Date:  2014-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.